![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 1, 240-249, April 2003
Department of Medicine, McGill University Health Centre (T.T.,
A.V.C., J.P., L.A.) and Lady Davis Institute (W.A.C., D.O.A.), McGill
University, Montreal, Quebec, Canada
In the passive Heymann nephritis (PHN) model of rat membranous
nephropathy, complement induces glomerular epithelial cell injury and
proteinuria, which is partially mediated by eicosanoids. Glomerular
cyclooxygenase (COX)-1 and -2 are up-regulated in PHN and contribute to
prostanoid generation. In the current study, we address the role of COX
isoforms in proteinuria, using the nonselective COX inhibitor
indomethacin and the COX-2-selective inhibitor
5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone (DFU). Four groups of rats with PHN were treated twice daily, from day
7 through 14 with vehicle, 1 mg/kg DFU, 10 mg/kg DFU, or 2 mg/kg
indomethacin. Vehicle-treated rats with PHN showed significant
proteinuria on day 14 (163 ± 15 mg/d, n = 19), compared with normal rats (10 ± 4 mg/d,
n = 3, p < 0.001). Treatment
with DFU (1 or 10 mg/kg) reduced proteinuria significantly (by
~33%), compared with vehicle, but to a lesser extent than
indomethacin (56% reduction). Glomerular eicosanoid generation was
reduced significantly in the DFU and indomethacin groups, compared with vehicle. There were no significant differences among vehicle- or
DFU-treated groups in [3H]inulin clearance, or in
glomerular expression of COX-1 and -2. DFU did not affect the
autologous immune response. In cultured rat glomerular epithelial
cells, COX inhibition reduced complement-induced cytotoxicity, and this
reduction was reversed by the thromboxane A2 analog
9,11-dideoxy-9
,11
-methanoepoxyprostaglandin F2
(U46619). Thus, in experimental membranous nephropathy,
selective inhibition of COX-2 reduces proteinuria, without adversely
affecting renal function. However, inhibition of both COX-1 and -2 is
required to achieve a maximum cytoprotective and antiproteinuric effect.
This article has been cited by other articles:
![]() |
M. Okamura, Y. Takano, N. Hiramatsu, K. Hayakawa, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1495 - F1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cohen, J. Papillon, L. Aoudjit, H. Li, A. V. Cybulsky, and T. Takano Role of calcium-independent phospholipase A2 in complement-mediated glomerular epithelial cell injury Am J Physiol Renal Physiol, March 1, 2008; 294(3): F469 - F479. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sankaran, N. Bankovic-Calic, M. R. Ogborn, G. Crow, and H. M. Aukema Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease Am J Physiol Renal Physiol, September 1, 2007; 293(3): F821 - F830. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. V. Cybulsky, L. Aoudjit, J. Zhu, H. Li, N. Lamarche-Vane, and T. Takano Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury Am J Physiol Renal Physiol, July 1, 2007; 293(1): F148 - F156. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky Cyclooxygenases, Prostanoids, and Glomerular Injury: Complex Relationships J. Am. Soc. Nephrol., February 1, 2007; 18(2): 367 - 368. [Full Text] [PDF] |
||||
![]() |
L. Aoudjit, A. Potapov, and T. Takano Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1534 - F1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, R. J. Quigg, and D. J. Salant Experimental membranous nephropathy redux Am J Physiol Renal Physiol, October 1, 2005; 289(4): F660 - F671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku, S. J. Shankland, and W. G. Couser Cellular Response to Injury in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, T. Takano, J. Papillon, A. Khadir, K. Bijian, and L. Le Berre The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2 Am J Physiol Renal Physiol, March 1, 2004; 286(3): F466 - F476. [Abstract] [Full Text] |
||||
![]() |
L. Aoudjit, M. Stanciu, H. Li, S. Lemay, and T. Takano p38 Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury Am J Physiol Renal Physiol, October 1, 2003; 285(4): F765 - F774. [Abstract] [Full Text] [PDF] |
||||